Search

Satralizumab

[L15536] Satralizumab is used in the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune inflammatory disorder of the central nervous system (CNS) involving demyelinating lesions … This novel mechanism effectively increases the duration of action of satralizumab, as it allows for single drug molecules to interact with multiple endogenous IL-6 receptors prior to elimination.

Glyceryl monostearate

Glycerol monostearate, commonly known as GMS, is the glycerol ester of stearic acid . It is commonly used as an emulsifier in foods.

Methyl salicylate 2-ethylbutyrate

Insulin pork

Composed of alpha and beta chains, processed from pro-insulin. Forms a hexameric structure.

Methadyl acetate

A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.

Atl146e

ATL146e is an anti-inflammatory compounds which is an agonist of A2A adenosine receptors.

Mecasermin

IGF-1 consists of 70 amino acids in a single chain with three intramolecular disulfide bridges and a molecular weight of 7649 daltons. … The amino acid sequence of the product is identical to that of endogenous human IGF-1.

Tasimelteon

In blind individuals, a lack of light stimulation causes an extension of the 24-hour circadian cycle and can lead to progressively delayed sleep onset. … Tasimelteon is a selective dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (N24HSWD).

Dihydralazine

Dihydralazine is under investigation in clinical trial NCT00311974 (The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals).

Lutetium Lu177 Edotreotide